Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wenzhou Kangning Hospital Co's earnings before interest and taxes (EBIT) for the
six
months ended in Jun. 2026 was HK$48 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$100 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Wenzhou Kangning Hospital Co's annualizedROC % for the quarter that ended in Jun. 2026 was 5.34%.
Wenzhou Kangning Hospital Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 5.88%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Wenzhou Kangning Hospital Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 6.56%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wenzhou Kangning Hospital Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wenzhou Kangning Hospital Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wenzhou Kangning Hospital Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Wenzhou Kangning Hospital Co's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$100 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wenzhou Kangning Hospital Co (HKSE:02120) has a EBIT of HK$100 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Wenzhou Kangning Hospital Co.
Is Wenzhou Kangning Hospital Co's EBIT too high?
Wenzhou Kangning Hospital Co's current EBIT is HK$100 Mil. Overall, Wenzhou Kangning Hospital Co has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wenzhou Kangning Hospital Co's EBIT compare to HCA and THC?
Wenzhou Kangning Hospital Co's EBIT of HK$100 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Wenzhou Kangning Hospital Co. Wenzhou Kangning Hospital Co's current EBIT is HK$100 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wenzhou Kangning Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co (HKSE:02120) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$13.13, compared to a current price of HK$9.26 — trading 29.5% below its estimated fair value. The current EBIT is HK$100 Mil. Wenzhou Kangning Hospital Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Wenzhou Kangning Hospital Co (HKSE:02120), the current EBIT is HK$100 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wenzhou Kangning Hospital Co (HKSE:02120) Overvalued in 2026?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co stock appears to be undervalued.
The current stock price of HK$9.26 is trading 29.5% below its estimated GF Value™ of HK$13.13.
GuruFocus considers Wenzhou Kangning Hospital Co to be Modestly Undervalued.
Key valuation signals for HKSE:02120:
EBIT: HK$100 Mil
GF Value™: HK$13.13 vs. price of HK$9.26 (29.5% below fair value)
No single metric tells the full story. See the HKSE:02120 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wenzhou Kangning Hospital Co Ltd is engaged in operating a network of healthcare facilities that focus on providing psychiatric specialty care and elderly rehabilitation service across various regions in China. It derives revenue from operating its owned hospitals consists of fees charged for outpatient visits and inpatient services at the group's various hospitals, which can be divided into treatment and general healthcare services and pharmaceutical sales, as well as variable considerations for medical services provided by the group, mainly including medical insurance settlement differences.
75GF Score
Get the complete analysis for HKSE:02120
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02120 has been successfully added to your 
